Correlation Between Processa Pharmaceuticals and Crossmark Steward

Can any of the company-specific risk be diversified away by investing in both Processa Pharmaceuticals and Crossmark Steward at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Processa Pharmaceuticals and Crossmark Steward into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Processa Pharmaceuticals and Crossmark Steward Equity, you can compare the effects of market volatilities on Processa Pharmaceuticals and Crossmark Steward and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Processa Pharmaceuticals with a short position of Crossmark Steward. Check out your portfolio center. Please also check ongoing floating volatility patterns of Processa Pharmaceuticals and Crossmark Steward.

Diversification Opportunities for Processa Pharmaceuticals and Crossmark Steward

0.08

Correlation Coefficient

Processa Pharmaceuticals  Crossmark Steward

Significant diversification

The 3 months correlation between Processa and Crossmark is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Processa Pharmaceuticals and Crossmark Steward Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crossmark Steward Equity and Processa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Processa Pharmaceuticals are associated (or correlated) with Crossmark Steward. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crossmark Steward Equity has no effect on the direction of Processa Pharmaceuticals i.e., Processa Pharmaceuticals and Crossmark Steward go up and down completely randomly.

Pair Corralation between Processa Pharmaceuticals and Crossmark Steward

Given the investment horizon of 90 days Processa Pharmaceuticals is expected to under-perform the Crossmark Steward. In addition to that, Processa Pharmaceuticals is 10.04 times more volatile than Crossmark Steward Equity. It trades about -0.04 of its total potential returns per unit of risk. Crossmark Steward Equity is currently generating about 0.02 per unit of volatility. If you would invest  2,964  in Crossmark Steward Equity on July 11, 2024 and sell it today you would earn a total of  4.00  from holding Crossmark Steward Equity or generate 0.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Processa Pharmaceuticals  vs.  Crossmark Steward Equity

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in November 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Crossmark Steward Equity

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Crossmark Steward Equity are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, Crossmark Steward is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Processa Pharmaceuticals and Crossmark Steward

The main advantage of trading using opposite Processa Pharmaceuticals and Crossmark Steward positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Processa Pharmaceuticals position performs unexpectedly, Crossmark Steward can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crossmark Steward will offset losses from the drop in Crossmark Steward's long position.

The idea behind Processa Pharmaceuticals and Crossmark Steward Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.